Pieter van der Meer is founder and managing partner of Gilde Healthcare. Pieter joined Gilde in 1998 following a consultant position with KPMG Management Consulting. He is co-responsible for general management, the investment committees and fundraising of the healthcare Venture & Growth and Private Equity funds.
Pieter is a Dutch national and speaks English and Spanish. He holds a Master’s degree in Chemistry from Leiden University specializing in bio-organic synthesis and molecular modeling. Pieter led investments in Ablynx, Acacia Pharma, Agendia, Inpharmatica, BG Medicine, Lumicks Technologies and NightBalance.
Pieter currently serves on the board of life sciences tools company Lumicks Technologies. In addition, he was involved with several exits and represented Gilde on the boards of antibody company Ablynx (BRU:ABLX), specialty pharma group Acacia Pharma (BRU: ACPH) and molecular diagnostics company BG Medicine (NASD:BGMD) until their respective listings at Euronext and NASDAQ. He was also board member of sleep apnea company NightBalance until it was acquired by Philips Healthcare.
